Matches in Nanopublications for { ?s ?p "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_provenance.
- assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP488414.RAgS8IT3FUXw7bgrXdlb91Qf7i4metAWRBvuRf1t2CTH8130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488414.RAgS8IT3FUXw7bgrXdlb91Qf7i4metAWRBvuRf1t2CTH8130_provenance.
- assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP813693.RA1a8VM5RM878Fstftc3TtuF8SzXQClypjuEKyDWie5TA130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813693.RA1a8VM5RM878Fstftc3TtuF8SzXQClypjuEKyDWie5TA130_provenance.
- NP817501.RA9jKv1WDMgwdBTo4K2sfUm711P2gsaFZmOPuOiIrI0Q0130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817501.RA9jKv1WDMgwdBTo4K2sfUm711P2gsaFZmOPuOiIrI0Q0130_provenance.
- assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1107622.RAcENbiWRL87qjUCyOt70p_H9-A6mRVOUTNeR8-GckoRQ130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1107622.RAcENbiWRL87qjUCyOt70p_H9-A6mRVOUTNeR8-GckoRQ130_provenance.
- NP751863.RAJD5bDZfjvrBqsySJGZRGt2d68XiPbGguM_ql5Y7RBcc130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751863.RAJD5bDZfjvrBqsySJGZRGt2d68XiPbGguM_ql5Y7RBcc130_provenance.
- NP1107624.RA2-BCwCO7AmgYfOAVpKG207uGvHbHn0q-DdV2PBF-eeY130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1107624.RA2-BCwCO7AmgYfOAVpKG207uGvHbHn0q-DdV2PBF-eeY130_provenance.